TRICHLORMETHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trichlormethiazide, and when can generic versions of Trichlormethiazide launch?
Trichlormethiazide is a drug marketed by Chartwell Rx, Impax Labs, Par Pharm, Sandoz, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in TRICHLORMETHIAZIDE is reserpine; trichlormethiazide. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine; trichlormethiazide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRICHLORMETHIAZIDE?
- What are the global sales for TRICHLORMETHIAZIDE?
- What is Average Wholesale Price for TRICHLORMETHIAZIDE?
Summary for TRICHLORMETHIAZIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| DailyMed Link: | TRICHLORMETHIAZIDE at DailyMed |

